213 related articles for article (PubMed ID: 8583779)
1. Double-blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud's phenomenon: the acute vasodilatory effect is not sustained.
Kingma K; Wollersheim H; Thien T
J Cardiovasc Pharmacol; 1995 Sep; 26(3):388-93. PubMed ID: 8583779
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
[TBL] [Abstract][Full Text] [Related]
3. Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin.
Shawket S; Dickerson C; Hazleman B; Brown MJ
Br J Clin Pharmacol; 1991 Aug; 32(2):209-13. PubMed ID: 1931469
[TBL] [Abstract][Full Text] [Related]
4. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.
Belch JJ; Newman P; Drury JK; McKenzie F; Capell H; Leiberman P; Forbes CD; Prentice CR
Lancet; 1983 Feb; 1(8320):313-5. PubMed ID: 6130329
[TBL] [Abstract][Full Text] [Related]
5. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
6. Intravenous nicardipine in Raynaud's phenomenon: a controlled trial.
van Heereveld H; Wollersheim H; Gough K; Thien T
J Cardiovasc Pharmacol; 1988 Jan; 11(1):68-74. PubMed ID: 2450259
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue.
Yardumian DA; Isenberg DA; Rustin M; Belcher G; Snaith ML; Dowd PM; Machin SJ
Br J Rheumatol; 1988 Jun; 27(3):220-6. PubMed ID: 2454140
[TBL] [Abstract][Full Text] [Related]
8. Prolonged remission in Raynaud's phenomenon after prostacyclin infusion.
Bellucci S; Kedra AW; Courmelle JM; Maclouf J; Boizard B; Dosquet-Bernard C; Tobelem G; Caen JP
Scand J Rheumatol; 1986; 15(4):392-8. PubMed ID: 3547631
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of prostacyclin infusions in healthy volunteers.
Wollersheim H; Thien T
Angiology; 1988 Mar; 39(3 Pt 1):227-33. PubMed ID: 2965535
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon.
Creager MA; Pariser KM; Winston EM; Rasmussen HM; Miller KB; Coffman JD
Am Heart J; 1984 Aug; 108(2):370-3. PubMed ID: 6380254
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of Raynaud's phenomenon in scleroderma with a new stable prostacyclin derivative].
Keller J; Kaltenecker A; Schricker KT; Krais T; Schönberger A; Gevatter M; Hornstein OP
Dtsch Med Wochenschr; 1984 Sep; 109(38):1433-8. PubMed ID: 6383760
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the Use of Epoprostenol to Treat Raynaud's Phenomenon With or Without Digital Ulcers.
Cruz JE; Ward A; Anthony S; Chang S; Bae HB; Hermes-DeSantis ER
Ann Pharmacother; 2016 Dec; 50(12):1060-1067. PubMed ID: 27465880
[TBL] [Abstract][Full Text] [Related]
13. Epoprostenol in patients with Raynaud's disease.
Fitscha P; Kaliman J; Weidinger F; Sinzinger H; O'Grady J
Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):23-7. PubMed ID: 3141936
[TBL] [Abstract][Full Text] [Related]
14. Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.
McHugh NJ; Csuka M; Watson H; Belcher G; Amadi A; Ring EF; Black CM; Maddison PJ
Ann Rheum Dis; 1988 Jan; 47(1):43-7. PubMed ID: 2449871
[TBL] [Abstract][Full Text] [Related]
15. Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.
Rademaker M; Thomas RH; Provost G; Beacham JA; Cooke ED; Kirby JD
Postgrad Med J; 1987 Aug; 63(742):617-20. PubMed ID: 2447572
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
Firth BG; Winniford MD; Campbell WB; Hillis LD
Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
[TBL] [Abstract][Full Text] [Related]
17. A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.
Mohrland JS; Porter JM; Smith EA; Belch J; Simms MH
Ann Rheum Dis; 1985 Nov; 44(11):754-60. PubMed ID: 3904643
[TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease.
Weber A; Bounameaux H
J Cardiovasc Pharmacol; 1990 May; 15(5):853-5. PubMed ID: 1692948
[TBL] [Abstract][Full Text] [Related]
19. The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension.
Franssen C; Wollersheim H; de Haan A; Thien T
J Clin Pharmacol; 1992 Jul; 32(7):652-9. PubMed ID: 1353506
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon.
Khan F; Coffman JD
Circulation; 1994 Mar; 89(3):1183-8. PubMed ID: 8124805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
